BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37597403)

  • 1. Therapeutic potential of infliximab for pruritus in mice model of cholestasis induced by bile duct ligation: Possible involvement of IL-31.
    Ebrahim Soltani Z; Elahi M; Khavandi M; Haddadi NS; Shayan M; Khalilzadeh M; Dehpour AR
    Int Immunopharmacol; 2023 Oct; 123():110806. PubMed ID: 37597403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
    Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
    Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
    Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
    Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis.
    Yurdakul Ertan H; Özbakış Dengiz G; Barut F; Yılmaz Ürün Y; Can M; Hussen SU; Üstündağ Y
    Turk J Gastroenterol; 2023 Jan; 34(1):62-72. PubMed ID: 36098363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of resistance to serotonin-induced itch in bile duct ligated mice.
    Ostadhadi S; Haddadi NS; Foroutan A; Azimi E; Elmariah S; Dehpour AR
    Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):680-685. PubMed ID: 28316077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus.
    Sanjel B; Maeng HJ; Shim WS
    Sci Rep; 2019 Jul; 9(1):10888. PubMed ID: 31350433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of nitric oxide in cholestasis-induced itch associated response in mice.
    Ostadhadi S; Foroutan A; Momeny M; Norouzi-Javidan A; Azimi E; Kordjazy N; Dehpour AR
    Biomed Pharmacother; 2016 Dec; 84():1367-1374. PubMed ID: 27802897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential TNF
    Shivakumar P; Mizuochi T; Mourya R; Gutta S; Yang L; Luo Z; Bezerra JA
    JCI Insight; 2017 Mar; 2(5):e88747. PubMed ID: 28289704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
    Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
    J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice via Peripheral and Central Mechanisms.
    Miao X; Huang Y; Liu TT; Guo R; Wang B; Wang XL; Chen LH; Zhou Y; Ji RR; Liu T
    Neurosci Bull; 2018 Feb; 34(1):42-53. PubMed ID: 28365861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.
    Inan S; Cowan A
    Pharmacol Biochem Behav; 2006 Sep; 85(1):39-43. PubMed ID: 16919318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.
    Hamid T; Gu Y; Ortines RV; Bhattacharya C; Wang G; Xuan YT; Prabhu SD
    Circulation; 2009 Mar; 119(10):1386-97. PubMed ID: 19255345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis.
    Gingold AR; Bergasa NV
    Life Sci; 2003 Oct; 73(21):2741-7. PubMed ID: 13679241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effect of
    Bae UJ; Park BH; Cho MK; Bae EJ
    J Med Food; 2022 Jun; 25(6):652-659. PubMed ID: 35708629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats.
    Tian B; Wang XL; Huang Y; Chen LH; Cheng RX; Zhou FM; Guo R; Li JC; Liu T
    Sci Rep; 2016 Nov; 6():36286. PubMed ID: 27824106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
    Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ
    J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation.
    Nabih ES; El-Kharashi OA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jan; 392(1):37-43. PubMed ID: 30203151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice.
    El Kasmi KC; Anderson AL; Devereaux MW; Balasubramaniyan N; Suchy FJ; Orlicky DJ; Shearn CT; Sokol RJ
    JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1096-1106. PubMed ID: 34664730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury
    Cao F; Liu P; Zhang X; Hu Y; Dong X; Bao H; Kong L; Wang L; Gong P
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.